ATE301195T1 - Acpl dna und polypeptide - Google Patents

Acpl dna und polypeptide

Info

Publication number
ATE301195T1
ATE301195T1 AT99903320T AT99903320T ATE301195T1 AT E301195 T1 ATE301195 T1 AT E301195T1 AT 99903320 T AT99903320 T AT 99903320T AT 99903320 T AT99903320 T AT 99903320T AT E301195 T1 ATE301195 T1 AT E301195T1
Authority
AT
Austria
Prior art keywords
polypeptides
acpl
acpl dna
dna
purified
Prior art date
Application number
AT99903320T
Other languages
English (en)
Inventor
John E Sims
Teresa L Born
Original Assignee
Immunex Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Immunex Corp filed Critical Immunex Corp
Application granted granted Critical
Publication of ATE301195T1 publication Critical patent/ATE301195T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00—Measuring for diagnostic purposes; Identification of persons
    • A61B5/41—Detecting, measuring or recording for evaluating the immune or lymphatic systems
    • A61B5/414—Evaluating particular organs or parts of the immune or lymphatic systems
    • A61B5/415—Evaluating particular organs or parts of the immune or lymphatic systems the glands, e.g. tonsils, adenoids or thymus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00—Measuring for diagnostic purposes; Identification of persons
    • A61B5/41—Detecting, measuring or recording for evaluating the immune or lymphatic systems
    • A61B5/414—Evaluating particular organs or parts of the immune or lymphatic systems
    • A61B5/417—Evaluating particular organs or parts of the immune or lymphatic systems the bone marrow
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/715—Receptors; Cell surface antigens; Cell surface determinants for cytokines; for lymphokines; for interferons
    • C07K14/7155—Receptors; Cell surface antigens; Cell surface determinants for cytokines; for lymphokines; for interferons for interleukins [IL]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Molecular Biology (AREA)
  • Immunology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biophysics (AREA)
  • Public Health (AREA)
  • Surgery (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pathology (AREA)
  • Medical Informatics (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Veterinary Medicine (AREA)
  • Biomedical Technology (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Vascular Medicine (AREA)
  • Physics & Mathematics (AREA)
  • Biochemistry (AREA)
  • Toxicology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicinal Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Endocrinology (AREA)
  • Cell Biology (AREA)
  • Hematology (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Saccharide Compounds (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
AT99903320T 1998-01-23 1999-01-22 Acpl dna und polypeptide ATE301195T1 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US7230198P 1998-01-23 1998-01-23
US7883598P 1998-03-20 1998-03-20
PCT/US1999/001420 WO1999037773A1 (en) 1998-01-23 1999-01-22 Acpl dna and polypeptides

Publications (1)

Publication Number Publication Date
ATE301195T1 true ATE301195T1 (de) 2005-08-15

Family

ID=26753223

Family Applications (1)

Application Number Title Priority Date Filing Date
AT99903320T ATE301195T1 (de) 1998-01-23 1999-01-22 Acpl dna und polypeptide

Country Status (11)

Country Link
US (7) US6664077B1 (de)
EP (1) EP1049777B1 (de)
JP (1) JP4409763B2 (de)
AT (1) ATE301195T1 (de)
AU (1) AU750767B2 (de)
CA (1) CA2318030C (de)
DE (1) DE69926480T2 (de)
ES (1) ES2245085T3 (de)
IL (3) IL137037A0 (de)
NZ (1) NZ505499A (de)
WO (1) WO1999037773A1 (de)

Families Citing this family (50)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6326472B1 (en) 1997-10-15 2001-12-04 Schering Corporation Human receptor proteins; related reagents and methods
US20020155526A1 (en) 1998-09-30 2002-10-24 Busfield Samantha J. Novel secreted immunomodulatory proteins and uses thereof
TWI335336B (de) 2000-02-10 2011-01-01 Abbott Gmbh & Co Kg
PH12012502440A1 (en) 2001-06-26 2013-06-17 Amgen Inc Antibodies to opgl
CA2824167C (en) 2002-09-06 2018-09-25 Amgen Inc. Therapeutic human anti-il-1r1 monoclonal antibody
US7968684B2 (en) * 2003-11-12 2011-06-28 Abbott Laboratories IL-18 binding proteins
US20050100965A1 (en) 2003-11-12 2005-05-12 Tariq Ghayur IL-18 binding proteins
US11111543B2 (en) 2005-07-29 2021-09-07 Natera, Inc. System and method for cleaning noisy genetic data and determining chromosome copy number
US9424392B2 (en) 2005-11-26 2016-08-23 Natera, Inc. System and method for cleaning noisy genetic data from target individuals using genetic data from genetically related individuals
US11111544B2 (en) 2005-07-29 2021-09-07 Natera, Inc. System and method for cleaning noisy genetic data and determining chromosome copy number
AR056806A1 (es) 2005-11-14 2007-10-24 Amgen Inc Moleculas quimericas de anticuerpo rankl- pth/ pthrp
CL2008002153A1 (es) 2007-07-24 2009-06-05 Amgen Inc Anticuerpo aislado o fragmanto de unión de antigeno del mismo que se une al receptor de il-18 (il-18r); molecula de ácido nucleico codificante; celula huesped que la comprende; composición farmaceutica; uso médico para tratar o prevenir una condición asociada con il-18r; método in vitro para inhibir la unión de il-18 al il-18r.
US11939634B2 (en) 2010-05-18 2024-03-26 Natera, Inc. Methods for simultaneous amplification of target loci
US11322224B2 (en) 2010-05-18 2022-05-03 Natera, Inc. Methods for non-invasive prenatal ploidy calling
US12152275B2 (en) 2010-05-18 2024-11-26 Natera, Inc. Methods for non-invasive prenatal ploidy calling
US10316362B2 (en) 2010-05-18 2019-06-11 Natera, Inc. Methods for simultaneous amplification of target loci
US20190010543A1 (en) 2010-05-18 2019-01-10 Natera, Inc. Methods for simultaneous amplification of target loci
US12221653B2 (en) 2010-05-18 2025-02-11 Natera, Inc. Methods for simultaneous amplification of target loci
DK3323830T3 (da) * 2010-06-19 2023-09-25 Memorial Sloan Kettering Cancer Center Anti-gd2 antibodies
AU2011358564B9 (en) 2011-02-09 2017-07-13 Natera, Inc Methods for non-invasive prenatal ploidy calling
EP2710481B1 (de) * 2011-05-20 2021-02-17 Intel Corporation Dezentralisierte zuordnung von ressourcen und verbindungsstrukturen zur unterstützung der ausführung von anweisungssequenzen durch mehrere maschinen
US20140100126A1 (en) 2012-08-17 2014-04-10 Natera, Inc. Method for Non-Invasive Prenatal Testing Using Parental Mosaicism Data
UY35148A (es) 2012-11-21 2014-05-30 Amgen Inc Immunoglobulinas heterodiméricas
WO2014144817A2 (en) 2013-03-15 2014-09-18 Amgen Inc. Inhibitory polypeptides specific to wnt inhibitors
CN105705165B (zh) 2013-03-15 2020-04-24 纪念斯隆-凯特琳癌症中心 高亲和力抗gd2抗体
EP3712166A1 (de) 2013-09-05 2020-09-23 Amgen Inc. Fc-haltige moleküle mit vorhersagbaren, konsistenten und reproduzierbaren glycoformprofilen
US10156562B2 (en) 2014-05-16 2018-12-18 Amgen Inc. Assay for detecting Th1 and Th2 cell populations
US20180173845A1 (en) 2014-06-05 2018-06-21 Natera, Inc. Systems and Methods for Detection of Aneuploidy
CA2979252C (en) * 2015-03-24 2023-01-03 ONE Media, LLC High priority notification system and method
WO2016183106A1 (en) 2015-05-11 2016-11-17 Natera, Inc. Methods and compositions for determining ploidy
WO2017181202A2 (en) 2016-04-15 2017-10-19 Natera, Inc. Methods for lung cancer detection
GB201618485D0 (en) 2016-11-02 2016-12-14 Ucl Business Plc Method of detecting tumour recurrence
AU2018235928B2 (en) 2017-03-14 2023-09-21 Amgen Inc. Control of total afucosylated glycoforms of antibodies produced in cell culture
AU2018288832B2 (en) 2017-06-20 2025-03-06 The Medical College Of Wisconsin, Inc. Assessing transplant complication risk with total cell-free DNA
JP2021506342A (ja) 2017-12-14 2021-02-22 ティーエーアイ ダイアグノスティックス インコーポレイテッドＴａｉ Ｄｉａｇｎｏｓｔｉｃｓ，Ｉｎｃ． 移植のための移植片適合性の評価
BR112020019559A2 (pt) 2018-03-26 2021-01-12 Amgen Inc. Glicoformas afucosiladas totais de anticorpos produzidos em cultura de células
CA3090426A1 (en) 2018-04-14 2019-10-17 Natera, Inc. Methods for cancer detection and monitoring by means of personalized detection of circulating tumor dna
US12234509B2 (en) 2018-07-03 2025-02-25 Natera, Inc. Methods for detection of donor-derived cell-free DNA
US11931674B2 (en) 2019-04-04 2024-03-19 Natera, Inc. Materials and methods for processing blood samples
MX2022003461A (es) 2019-09-26 2022-04-19 Amgen Inc Metodos de produccion de composiciones de anticuerpos.
WO2021236962A1 (en) 2020-05-20 2021-11-25 The Medical College Of Wisconsin, Inc. Compositions and methods for inhibiting cytokine-release syndrome
WO2021247892A1 (en) 2020-06-04 2021-12-09 Amgen Inc. Assessment of cleaning procedures of a biotherapeutic manufacturing process
AU2021360897A1 (en) 2020-10-15 2023-05-25 Amgen Inc. Relative unpaired glycans in antibody production methods
EP4352094A1 (de) 2021-06-07 2024-04-17 Amgen Inc. Verwendung von fucosidase zur steuerung des afucosylierungsniveaus glykosylierter proteine
AU2022361382A1 (en) 2021-10-05 2024-03-28 Amgen Inc. Fc-gamma receptor ii binding and glycan content
WO2023215725A1 (en) 2022-05-02 2023-11-09 Fred Hutchinson Cancer Center Compositions and methods for cellular immunotherapy
WO2024220916A1 (en) 2023-04-20 2024-10-24 Amgen Inc. Methods of determining relative unpaired glycan content
WO2025038600A1 (en) 2023-08-14 2025-02-20 Amgen Inc. Methods for reducing yellow color
WO2025101820A1 (en) 2023-11-08 2025-05-15 Fred Hutchinson Cancer Center Compositions and methods for cellular immunotherapy
CN119192384A (zh) * 2024-10-25 2024-12-27 杭州华安生物技术有限公司 抗人Acp1蛋白的兔单克隆抗体及其应用和产品

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2120949T4 (es) * 1990-06-28 2011-12-29 Sanofi-Aventis Deutschland Gmbh 50% Proteinas de fusión con porciones de inmunoglobulinas, su preparación y empleo.
WO1999019480A2 (en) * 1997-10-15 1999-04-22 Schering Corporation Human receptor proteins; related reagents and methods
US6326472B1 (en) 1997-10-15 2001-12-04 Schering Corporation Human receptor proteins; related reagents and methods

Also Published As

Publication number Publication date
US20090004674A1 (en) 2009-01-01
AU2337399A (en) 1999-08-09
US20030003542A1 (en) 2003-01-02
JP4409763B2 (ja) 2010-02-03
US6692740B2 (en) 2004-02-17
ES2245085T3 (es) 2005-12-16
CA2318030A1 (en) 1999-07-29
IL212140A0 (en) 2011-06-30
DE69926480D1 (de) 2005-09-08
US20110027805A1 (en) 2011-02-03
DE69926480T2 (de) 2006-04-13
EP1049777A1 (de) 2000-11-08
IL137037A0 (en) 2001-06-14
US6693171B2 (en) 2004-02-17
US7993845B2 (en) 2011-08-09
IL137037A (en) 2011-05-31
CA2318030C (en) 2009-02-17
IL212140A (en) 2013-05-30
NZ505499A (en) 2002-07-26
US20040138421A1 (en) 2004-07-15
WO1999037773A1 (en) 1999-07-29
US20030100062A1 (en) 2003-05-29
US20040248254A1 (en) 2004-12-09
US6664077B1 (en) 2003-12-16
EP1049777B1 (de) 2005-08-03
JP2002500887A (ja) 2002-01-15
AU750767B2 (en) 2002-07-25
US7838248B2 (en) 2010-11-23
US7270817B2 (en) 2007-09-18

Similar Documents

Publication Publication Date Title
ATE301195T1 (de) Acpl dna und polypeptide
ATE362534T2 (de) Menschliche tslp nukleinsäuren und polypeptide
ATE305510T1 (de) Zelloberflächenglycoproteinen zusammenhang mit menschlicher b zell lymphomen - ulbp, dns und polypeptiden
ATE447583T1 (de) Polypeptide und dafür kodierende nukleinsäure
CY1107594T1 (el) DNA ΚΑΙ ΠΟΛΥΠΕΠΤΙΔΙΑ IL-1η
ATE534742T1 (de) Polypeptide und nukleinsäuren von phorphorymonas gingivalis
FI930626A0 (fi) Proteinstruktur hos vaexttoxingelonin
WO1999041388A3 (en) Metalloprotease-disintegrins svph3-13 and svph3-17 dna and polypeptides
DE69932259D1 (de) Il-1zeta, il-1zeta spleissvarianten, und xrec2 dnas und polypeptide
WO2000008180A3 (en) HUMAN cDNAs ENCODING POLYPEPTIDES HAVING KINASE FUNCTIONS
DE69932247D1 (de) Menschlisches il-1 epsilon dna und polypeptide
WO2001055211A3 (en) Fil-1 theta dnas and polypeptides
WO1999031256A3 (en) Cathepsin dc proteins, dna encoding the proteins, and their use in human cancer prognosis
WO2000008177A3 (en) Death associated kinase containing ankyrin repeats (dakar)
WO2000043525A3 (en) Metalloproteinase-disintegrin family members: svph dnas and polypeptides
DE60124380D1 (de) Angiogenese-assoziierte proteine und dafür kodierende nukleinsäure
WO2000008178A3 (en) Murine dna molecules encoding polypeptides having kinase functions
DK1078072T3 (da) Nye peptidfragmenter til oprensning af proteiner
EP1690871A3 (de) Xrec2 DNS und Polypeptide

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1049777

Country of ref document: EP